A DBS neuromodulation approach of the ARC to treat obesity would preferably activate selectively the anorexigenic POMC and/or inactivate the orexigenic AgRP/NPY neurons. The gene discussed is POMC; the disease is obesity due to melanocortin 4 receptor deficiency.